Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ambu A/S: Capital increase in connection with exercise of warrants

Ambu A/S
Posted on: 09 Feb 18


In December 2014, Ambu A/S issued 2,000,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. These warrants were issued to 22 employees with a vesting period of three years and may therefore be exercised in the trading window, which was opened on 31 January 2018 in connection with Ambu's interim financial report for Q1 2017/18.

Lars Marcher, President & CEO, tel. +45 5136 2490, email:

Company announcement no. 17 2017_18

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire

Last updated on: 10/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.